Chronic Coronary Syndromes (CCS) represent a persistent healthcare challenge characterized by long-term cardiovascular risk. Despite advancements in primary prevention and treatment modalities, residual risk remains a significant concern. This abstract explores the imperative of addressing residual risk in CCS through the development of clinical pathways focused on quality-centric secondary prevention strategies. By integrating evidence-based interventions, personalized risk assessment, patient engagement and multidisciplinary care, these clinical pathways aim to optimize long-term outcomes and enhance the overall quality of life for individuals with CCS. This article provides an overview of the rationale, components and potential impact of quality-driven secondary prevention pathways, emphasizing their role in mitigating residual risk and advancing cardiovascular care in CCS.
HTML PDFShare this article
